Olivier Brandicourt, M.D.

Olivier Brandicourt, M.D.

DirectoratVaxcyte· In the 2025 proxy

Olivier Brandicourt, M.D. sits on 5 public boards.

Boards1

  • VaxcyteDirector · 0 yr on the boardIndependent—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. VaxcytePublic company · 1 yr
    • Director2025 – Present · 1 yrStock in role -28%
  2. BeOne Medicines Ltd.Public company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  3. AvenCell Therapeutics, Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  4. Alnylam Pharmaceuticals, Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  5. Dewpoint Therapeutics, Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?